NEW YORK, March 11 (GenomeWeb News) - A recently released guidance issued by the US Food and Drug Administration will make it easier for Roche and Affymetrix rivals to win FDA clearance for tests that resemble the AmpliChip drug-metabolism diagnostic, GenomeWeb News has learned.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.